{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:06:50Z","timestamp":1791493610263,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["2014\/001"],"award-info":[{"award-number":["2014\/001"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tuberculosis (TB) control programmes rely heavily on laboratories to support both clinical care and public health. Qualified personnel with adequate technical and managerial skills comprise an integral component of any quality assured laboratory. Training a new generation of TB laboratory specialists was identified as a critical priority in the European Union \/European Economic Area (EU\/EEA). A tailored training programme for TB reference laboratory professionals was developed and implemented within the European Reference Laboratory Network for Tuberculosis to increase the pool of technical experts available to step into leadership roles in the TB laboratory community. Three cohorts of selected laboratory specialists participated in a series of trainings from 2009 to 2016.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted an evaluation of the training programme using a structured questionnaire administered via the EUSurvey website, with the aim of documenting the benefits and contribution as well as suggesting improvements and future direction of the programme. All graduated participants and all current ERLTB-Net members were invited to participate in the online survey and descriptive quantitative analysis was performed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The evaluation found significant benefits for both the participants and the participants\u2019 institutions, with improvements being reported in laboratory practices and management including implementation of new diagnostic techniques and career progression for participants. The training programme differed from other international and European initiatives in a number of important ways; the curriculum is unique in the scope and range of topics covered; the programme targets senior level professionals and future directors; cohorts were limited to 8\u201310 participants; and the programme involved a number of workshops (5\u20137) taking place over a two-year period. Relationships and collaborations established between individuals and institutions were valued as an important success of the initiative. Suggestions on how the impact of the programme could be enhanced included equipping participants to perform laboratory assessments in low-resource settings outside the EU, thus bolstering global TB control.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Based on the findings presented the training programme has proved to be successful in developing leadership, expertise, partnerships and networks to support TB laboratories and has contributed significant benefits to strengthening European National Reference laboratories in the fight against TB.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12913-020-05240-3","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:04:10Z","timestamp":1589205850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["European Union training programme for tuberculosis laboratory experts: design, contribution and future direction"],"prefix":"10.1186","volume":"20","author":[{"given":"Philomena","family":"Raftery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"K\u00f6dm\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladyslav","family":"Nikolayevskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"5240_CR1","unstructured":"World Health Organization Regional Office for Europe. TB in the WHO European Region. http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/tuberculosis\/tuberculosis-read-more. Accessed 14 Dec 2018."},{"key":"5240_CR2","unstructured":"World Health Organization. Global tuberculosis report. Geneva; 2019. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed 23 Feb 2020."},{"key":"5240_CR3","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2016 data. European Centre for Disease Prevention and Control. https:\/\/ecdc.europa.eu\/en\/publications-data\/tuberculosis-surveillance-and-monitoring-europe-2018#copy-to-clipboard. Accessed 20 Aug 2018."},{"key":"5240_CR4","volume-title":"Tuberculosis surveillance and monitoring in Europe 2015","author":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe","year":"2015","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2015. Stockholm: European Centre for Disease Prevention and Control; 2015."},{"key":"#cr-split#-5240_CR5.1","doi-asserted-by":"crossref","unstructured":"Drobniewski FA, Nikolayevskyy V, Hoffner S, Pogoryelova O, Manissero D, Ozin AJ. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2008;13","DOI":"10.2807\/ese.13.12.08076-en"},{"key":"#cr-split#-5240_CR5.2","unstructured":"(12) Epub 2008\/09\/03. PubMed PMID: 18761994."},{"key":"5240_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1741-7015-11-190","volume":"11","author":"F Drobniewski","year":"2013","unstructured":"Drobniewski F, Nikolayevskyy V, Maxeiner H, Balabanova Y, Casali N, Konsevaya I, Ignatyeva O. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med. 2013;11:190.","journal-title":"BMC Med"},{"issue":"7","key":"5240_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.5588\/ijtld.12.0180","volume":"16","author":"F Drobniewski","year":"2012","unstructured":"Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D. D. P. diagnosis of tuberculosis and drug resistance: what can new tools bring us? Int J Tuberc Lung Dis. 2012;16(7):860\u201370. https:\/\/doi.org\/10.5588\/ijtld.12.0180 Epub 2012\/06\/13. PubMed PMID: 22687497.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"5240_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/fmb.10.165","volume":"6","author":"M Kato-Maeda","year":"2011","unstructured":"Kato-Maeda M, Metcalfe JZ, Flores L. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol. 2011;6(2):203\u201316. https:\/\/doi.org\/10.2217\/fmb.10.165 Epub 2011\/03\/04. PubMed PMID: 21366420; PubMed Central PMCID: PMCPMC4296029.","journal-title":"Future Microbiol"},{"issue":"12","key":"5240_CR9","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1101\/cshperspect.a021188","volume":"4","author":"S Niemann","year":"2014","unstructured":"Niemann S, Supply P. Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches. Cold Spring Harbor perspectives in medicine. 2014;4(12):2157\u20131422. https:\/\/doi.org\/10.1101\/cshperspect.a021188 Epub 2014\/09\/06. PubMed PMID: 25190252; PubMed Central PMCID: PMCPMC4292095.","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"5","key":"5240_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2471\/06.039081","volume":"85","author":"JC Ridderhof","year":"2007","unstructured":"Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ. 2007;85(5):354\u20139. https:\/\/doi.org\/10.2471\/06.039081 PubMed PMID: PMC2636656.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"5240_CR11","doi-asserted-by":"publisher","first-page":"e0152926","DOI":"10.1371\/journal.pone.0152926","volume":"11","author":"V Nikolayevskyy","year":"2016","unstructured":"Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf M, K\u00f6dm\u00f6n C, et al. External quality assessment for tuberculosis diagnosis and drug resistance in the European Union: a five year multicentre implementation study. PLoS ONE. 2016;11(4):e0152926. https:\/\/doi.org\/10.1371\/journal.pone.0152926 PubMed PMID: PMC4824391.","journal-title":"PLoS ONE"},{"key":"5240_CR12","unstructured":"Stop TB. Global Laboratory Initiative (GLI). http:\/\/www.stoptb.org\/wg\/gli\/. Accessed 14 Dec 2018."},{"key":"5240_CR13","unstructured":"World Health Organization. Global Laboratory Initiative (GLI). http:\/\/www.who.int\/tb\/areas-of-work\/laboratory\/gli\/en\/. Accessed 14 Dec 2018."},{"key":"5240_CR14","unstructured":"World Health Organization Regional Office for Europe. European TB Laboratory Initiative (ELI). http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/tuberculosis\/areas-of-work\/laboratory-diagnosis\/about-the-european-tuberculosis-laboratory-initiative-eli. Accessed 14 Dec 2018."},{"key":"5240_CR15","unstructured":"World Health Organization. The End TB Strategy. http:\/\/www.who.int\/tb\/End_TB_brochure.pdf. Accessed 14 Dec 2018."},{"key":"5240_CR16","doi-asserted-by":"crossref","unstructured":"Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G, Thomsen V. Recommended standards for modern tuberculosis laboratory services in Europe. Eur Respir J. 2006. PubMed PMID: 16899481.","DOI":"10.1183\/09031936.06.00084906"},{"key":"5240_CR17","unstructured":"European Centre for Disease Prevention and Control. European Reference Laboratory Network for TB (ERLTB-Net). https:\/\/ecdc.europa.eu\/en\/about-us\/partnerships-and-networks\/disease-and-laboratory-networks\/erltb-net. Accessed 14 Dec 2018."},{"issue":"11","key":"5240_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/ehjci\/jev213","volume":"16","author":"E Surkova","year":"2015","unstructured":"Surkova E, Muraru D, Grapsa J, Donal E, Lancellotti P, Habib G, et al. Eight years of the EACVI's grant programme: existing developments, impact, and steps forward. Eur Heart J Cardiovasc Imaging. 2015;16(11):1178\u20139. https:\/\/doi.org\/10.1093\/ehjci\/jev213 Epub 2015\/09\/10. PubMed PMID: 26351401.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"5240_CR19","doi-asserted-by":"publisher","first-page":"e0006135","DOI":"10.1371\/journal.pntd.0006135","volume":"12","author":"P Raftery","year":"2018","unstructured":"Raftery P, Condell O, Wasunna C, Kpaka J, Zwizwai R, Nuha M, et al. Establishing Ebola virus disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: impact on outbreak response, case management and laboratory systems strengthening. PLoS Negl Trop Dis. 2018;12(1):e0006135. https:\/\/doi.org\/10.1371\/journal.pntd.0006135.","journal-title":"PLoS Negl Trop Dis"},{"key":"5240_CR20","doi-asserted-by":"publisher","unstructured":"Perkins MD, Dye C, Balasegaram M, Br\u00e9chot C, Mombouli J-V, R\u00f8ttingen J-A, et al. Diagnostic preparedness for infectious disease outbreaks. Lancet. 2017. https:\/\/doi.org\/10.1016\/S0140-6736(17)31224-2.","DOI":"10.1016\/S0140-6736(17)31224-2"},{"key":"5240_CR21","doi-asserted-by":"publisher","unstructured":"Perkins MD, Kessel M. What Ebola tells us about outbreak diagnostic readiness. Nat Biotech. 2015;33(5):464\u20139. https:\/\/doi.org\/10.1038\/nbt.3215.","DOI":"10.1038\/nbt.3215"},{"key":"5240_CR22","doi-asserted-by":"publisher","unstructured":"Tang Y-W, Schmitz JE, Persing DH, Stratton CW. The laboratory diagnosis of COVID-19 infection: current issues and challenges. J Clin Microbiol. 2020;JCM:00512\u201320. https:\/\/doi.org\/10.1128\/jcm.00512-20.","DOI":"10.1128\/jcm.00512-20"},{"issue":"4","key":"5240_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5588\/ijtld.17.0564","volume":"22","author":"V Mathys","year":"2018","unstructured":"Mathys V, Roycroft E, Raftery P, Groenheit R, Folkvardsen DB, Homorodean D, et al. Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study. Int J Tuberc Lung Dis. 2018;22(4):444\u201351. https:\/\/doi.org\/10.5588\/ijtld.17.0564 Epub 2018\/03\/23. PubMed PMID: 29562994; PubMed Central PMCID: PMCPMC5868372.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5240_CR24","unstructured":"World Health Organization. Global Laboratory Leadership programme. https:\/\/www.who.int\/ihr\/lyon\/global-laboratory-leadership-programme\/en\/. Accessed 23 Feb 2020."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:08:01Z","timestamp":1620691681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5240"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05240-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study as it was an evaluation of a training programme. By participating in the survey, participants gave written consent for their contribution to be used as part of the evaluation. The study was an observational study with an aim of quality improvement where no private, sensitive, personal or health data was collected or analysed. Names or surnames were not stored with the data and all identifiers were removed before data analysis and stored securely. The lead author did not have access to personal data. Therefore, we declare that no personal information was collected or analysed and as such no ethics permission was required for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}